Impact of Donor Type and Melphalan Dose on Allogeneic Transplant Outcomes for Patients with Lymphoma.

Biology of Blood and Marrow Transplantation（2019）

引用 7|浏览31

暂无评分

摘要

•Haploidentical transplants with post-transplantation cyclophosphamide have similar long-term survival as seen with HLA-matched donor transplants.•The FM100 regimen is associated with similar survival as the FM140 regimen for patients with lymphoma, although it is used primarily in older patients.

查看译文

关键词

Allogeneic transplantation,Hodgkin lymphoma,Non-Hodgkin lymphoma,Haploidentical transplantation,Melphalan conditioning,FM100 regimen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要